Trade Unlisted is not regulated by the Securities and Exchange Board of India (SEBI). Investments in unlisted securities involve significant risk, including the risk of complete loss of capital. The filing of a Draft Red Herring Prospectus (DRHP) does not guarantee that an Initial Public Offering (IPO) will occur. Unlisted securities are inherently illiquid, price discovery may be limited, and exit opportunities may not materialize.
Trade Unlisted provides news, insights, and general market information for informational and educational purposes only. The content should not be construed as financial, investment, legal, or tax advice. Trade Unlisted does not act as a broker, investment advisor, fiduciary, or intermediary, and does not endorse, recommend, solicit, or validate any investment opportunity. Users are solely responsible for conducting their own independent due diligence before making any financial or investment decisions.
All information is derived from publicly available sources and market observations. While reasonable care is taken in preparing content, Trade Unlisted makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of the information provided. Users should independently verify all information prior to relying on it.
World Liver Day: Care Health Insurance Highlights Surge in Liver Disease Cases in India
World Liver Day: Care Health Insurance Highlights Surge in Liver Disease Cases in India
Publish Date :
World Liver Day: Care Health Insurance Highlights Surge in Liver Disease Cases in India
Rising Liver Disease Burden in India
India is witnessing a growing but largely under-recognized liver health crisis
Non-Alcoholic Fatty Liver Disease (NAFLD) affects nearly 1 in 3 Indians, with prevalence ranging between 9%–32%
Liver-related conditions contribute significantly to overall mortality and are increasingly being termed a “silent epidemic”
Sharp Increase in Insurance Claims and Costs
Liver disease-related insurance claims have doubled over the past three years
Treatment costs have also nearly doubled, making liver disease one of the most expensive medical conditions
A health insurance cover of ₹15 lakh or more is now becoming a baseline for adequate protection
Changing Demographics of Liver Disease
Cases are no longer limited to older individuals or metro cities
Key trends:
5–10% annual rise among younger individuals
10–15% yearly increase in Tier 2 and Tier 3 cities
Around 10% annual rise in cases among women
Indicates a broadening risk profile across age, gender, and geography
Shift in Disease Patterns
Liver disease is becoming:
More widespread geographically
More severe in nature
Increasing cases are linked to:
Lifestyle changes
Obesity and metabolic disorders
Fatty liver disease is emerging as a leading cause of chronic liver conditions, even among children
Economic Impact on Households
Liver disease is no longer just a medical issue—it is also a financial burden
Rising costs and complex treatment pathways are putting significant pressure on household finances
Without adequate insurance, treatment can be financially devastating
Expert Viewpoint
According to Care Health Insurance leadership:
Liver disease cases are rising sharply and affecting younger populations
The financial burden is increasing significantly
There is a need for:
Regular health check-ups
Adequate insurance coverage
Greater awareness
Policy & Healthcare Context
Government has included NAFLD screening under the National Programme for Non-Communicable Diseases (NP-NCD)
However, policy efforts need to be complemented by individual financial preparedness
Future Risk Outlook
By 2040, over 1.19 crore Indian children could be affected by liver disease if trends continue
Indicates a long-term public health challenge driven by lifestyle factors
Comments